Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Long-term outcomes of daratumumab, bortezomib, and dexamethasone in previously treated patients with multiple myeloma.

Long-term outcomes of daratumumab, bortezomib, and dexamethasone in previously treated patients with multiple myeloma.

Posted by on Sep 20, 2020 in Multiple Myeloma | 0 comments

In a nutshell This trial was carried out to examine the long-term safety and effectiveness of daratumumab (Darzalex) plus bortezomib (Velcade) and dexamethasone (Dexasone) in patients with previously treated multiple myeloma (MM). The authors concluded that after 3-years this treatment maintained benefit and...

Read More

Does freezing of embryos improve live birth rates in women of advanced reproductive age?

Does freezing of embryos improve live birth rates in women of advanced reproductive age?

Posted by on Sep 20, 2020 in Infertility | 0 comments

In a nutshell This study investigated live birth rates (LBRs) in women that underwent frozen (Fz) embryo transfer (ET).  They found that LBRs were higher with Fz-ET in women under 35, but there was no difference between Fz and fresh (Fr) ET in those older than 35. Some background Infertility is a common condition. Assisted reproductive technology...

Read More

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Posted by on Sep 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D). It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients. Some background T2D is a...

Read More

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Posted by on Sep 20, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of a gentler stem cell transplant (SCT) from a partially matched donor for patients with advanced lymphoma. It found that haploidentical SCT is an effective treatment option for these patients. Some background Lymphomas are a group of cancers of white blood cells within the lymph nodes. Common types...

Read More

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Evaluating haploidentical stem cell transplantation for advanced lymphoma

Posted by on Sep 20, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at the effect of a gentler stem cell transplant (SCT) from a partially matched donor for patients with advanced lymphoma. It found that haploidentical SCT is an effective treatment option for these patients. Some background Lymphomas are a group of cancers of white blood cells within the lymph nodes. Common types...

Read More

Repetitive transcranial magnetic stimulation improves the treatment outcomes of patients with Parkinson’s disease

Repetitive transcranial magnetic stimulation improves the treatment outcomes of patients with Parkinson’s disease

Posted by on Sep 20, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of repetitive transcranial magnetic stimulation (RTMS) in the treatment of patients with Parkinson's disease (PD). Researchers suggested that RTMS improves walking ability in these patients. Some background PD affects brain cells, which are responsible for controlling body functions. This...

Read More

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Posted by on Sep 19, 2020 in Overactive bladder | 0 comments

In a nutshell This study reviewed the outcomes of onabotulinumtoxinA (BTX) and sacral neuromodulation (SNM) in the treatment of overactive bladder (OAB). Researchers suggested that both treatments improved the outcomes of these patients, but BTX may be associated with more complications. Some background OAB of an uncontrolled need to urinate...

Read More

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Posted by on Sep 19, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study reviewed the effectiveness of water vapor thermal therapy (WVTT) as a treatment for urinary symptoms related to benign prostatic hyperplasia (BPH). Researchers suggested that this therapy improves the outcomes of these patients. Some background BPH consists of the enlargement of the prostate gland and is a common condition in...

Read More

FOLFOXIRI plus bevacizumab improves survival of patients with advanced colorectal cancer

FOLFOXIRI plus bevacizumab improves survival of patients with advanced colorectal cancer

Posted by on Sep 19, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of different chemotherapy treatments in patients with inoperable advanced colorectal cancer (CRC). Researchers suggested that FOLFOXIRI plus bevacizumab (Avastin) significantly improved the survival of these patients. Some background Around 20% of patients present with advanced CRC at diagnosis....

Read More

Can removal of metastasis improve overall survival in patients with melanoma who responded to targeted therapy?

Can removal of metastasis improve overall survival in patients with melanoma who responded to targeted therapy?

Posted by on Sep 19, 2020 in Melanoma | 0 comments

In a nutshell This study was carried out to assess the effectiveness of metastasectomy (ME; surgical removal of tumors that have spread from the original tumor location) for patients with advanced melanoma who responded to targeted or immunotherapy. The authors found that ME for melanoma is associated with a longer overall survival (OS) in...

Read More

Looking at a drug-free implantable device to provide relief for urinary and sexual functions

Looking at a drug-free implantable device to provide relief for urinary and sexual functions

Posted by on Sep 17, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study investigated the short-term functional changes and complications for the drug-free nitinol implantable device (iTind) for patients with benign prostatic hyperplasia (BPH).  The study showed that iTind is a low-risk device that can help maintain and even improve urinary and sexual function in these patients. Some...

Read More